Sale

Allergy Treatment Market

Global Allergy Treatment Market Share, Size, Growth, Report: By Type: Eye Allergy, Rhinitis, Asthma, Skin Allergy, Food Allergies, Others; By Treatment: Anti-Allergy Drugs, Immunotherapy; By Route of Administration: Oral, Inhalation, Intranasal, Others; By End User: Hospitals, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Allergy Treatment Market Outlook

The global allergy treatment market size attained a value of USD 21.62 billion in 2023 driven by rising demand for Immunotherapy and Anti-Allergy Drugs. The market is anticipated to grow at a CAGR of 6.5% during the forecast period of 2024-2032 to attain a value of USD 38.11 billion by 2032.

 

Global Allergy Treatment Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Cases of Asthma and the Growing Risk of Allergies to Bolster the Growth of the Allergy Treatment Industry

The increasing demand for medical treatments to control asthma is anticipated to aid the market growth in the forecast period. The growing prevalence of asthma among children, geriatrics, and adults owing to the rising pollution levels is contributing to the demand for anti-allergy drugs and immunotherapy. Reckless attitude towards asthma or a lack of knowledge about allergy can lead to airway remodelling, which is a brutal condition. The increasing awareness about the various treatment options available to treat these conditions is likely to bolster the growth of the global allergy treatment industry.

 

North America Accounts for a Significant Share in the Market

The growing concerns about the need to counter allergies owing to the rising geriatric population are likely to be a major factor driving the allergy treatment industry growth in the region. In addition, the increasing healthcare expenditure and the development of clinics and hospitals in the region are significantly contributing to the market expansion. Furthermore, the market is expected to be aided by the availability of skilled medical professionals who specialise in asthma and eye allergy treatments in countries like the United States and Canada.

 

Allergy Treatment: Market Segmentation

Allergy treatment is defined as the process of treating an allergy using medicines or allergy shots, or by assisting an individual to avoid a particular substance to prevent further reactions. Allergy treatment may include options like antihistamines and avoiding allergens.

 

Global Allergy Treatment Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Based on type, the market is segmented into:

  • Eye Allergy
  • Rhinitis
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Others

On the basis of treatment, the market is divided into:

  • Anti-Allergy Drugs
  • Immunotherapy

Among these, while the anti-allergy drugs segment is further divided into antihistamines, corticosteroids, decongestants, and other drugs, the immunotherapy segment is further categorised into sub-cutaneous immunotherapy (SCIT) and sub-lingual immunotherapy (SLIT) based on type.

The regional markets for allergy treatment include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Allergy Treatment Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Demand for Immunotherapy and Anti-Allergy Drugs to Boost the Growth of the Allergy Treatment Industry

The global allergy treatment industry is driven by the growing popularity of various anti-allergy drugs such as antihistamines, which are extremely beneficial for treating patients suffering from allergic reactions to pollen or other allergens. Antihistamines are also used to treat other conditions such as stomach problems, cold, and anxiety, among others. Furthermore, the market is anticipated to be augmented by the rising demand for immunotherapy owing to the fact that this type of treatment is ideal for long-term. The demand for immunotherapy is likely to be propelled by the surging cases of allergy rhinitis, allergic asthma, conjunctivitis, and stinging insect allergy, among others.

 

Key Industry Players in the Global Allergy Treatment Market

The report gives a detailed analysis of the following key players in the global allergy treatment market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • AbbVie Inc.
  • GlaxoSmithKline PLC
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson Services, Inc.
  • Sanofi S.A.
  • LETI Pharma, S.L.U.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Treatment
  • Route of Administration
  • End User
  • Region
Breakup by Type
  • Eye Allergy
  • Rhinitis
  • Asthma
  • Skin Allergy
  • Food Allergies
  • Others
Breakup by Treatment
  • Anti-Allergy Drugs
  • Immunotherapy
Breakup by Route of Administration
  • Oral
  • Inhalation
  • Intranasal
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • AbbVie Inc.
  • Sanofi S.A.
  • Johnson & Johnson Services, Inc.
  • LETI Pharma, S.L.U.
  • GlaxoSmithKline Plc.
  • Zenomed Healthcare Private Limited
  • F. Hoffmann-La Roche AG
  • Cadila Pharmaceuticals
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd.
  • Akorn, Incorporated
  • Prestige Consumer Healthcare Inc.
  • Astellas Pharma Inc.
  • Eli Lilly and Company
  • Almirall, S.A

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Allergy Overview

    3.1    Guidelines and Stages
    3.2    Pathophysiology
    3.3    Screening and Diagnosis
    3.4    Treatment Pathway 
4    Patient Profile
    4.1    Patient Profile Overview
    4.2    Patient Psychology and Emotional Impact Factors
    4.3    Risk Assessment and Treatment Success Rate
5    Allergy Treatment Epidemiology Analysis
    5.1    Epidemiology Overview (2016-2031)
    5.2    North America Allergy Treatment Epidemiology (2016-2031)
    5.3    Europe Allergy Epidemiology (2016-2031)
    5.4    Asia-Pacific Allergy Epidemiology (2016-2031)
    5.5    Latin America Allergy Epidemiology (2016-2031)
    5.6    Middle East & Africa Allergy Epidemiology (2016-2031)
6    Global Allergy Treatment Market Overview 
    6.1    Global Allergy Treatment Market Historical Value (2017-2023)
    6.2    Global Allergy Treatment Market Forecast Value (2024-2032)
7    Global Allergy Treatment Market Landscape
    7.1    Allergy Treatment: Developers Landscape
        7.1.1    Analysis by Year of Establishment
        7.1.2    Analysis by Company Size
        7.1.3    Analysis by Region
    7.2    Allergy Treatment: Product Landscape
        7.2.1    Analysis by Type
        7.2.2    Analysis by Treatment
        7.2.3    Analysis by Route of Administration
        7.2.4    Analysis by End User
8    Allergy Treatment Challenges and Unmet Needs
    8.1    Treatment Pathway Challenges
    8.2    Compliance and Drop-Out Analysis
    8.3    Awareness and Prevention Gaps
9    Cost of Treatment
10    Global Allergy Treatment Market Dynamics

    10.1    Market Drivers and Constraints
    10.2    SWOT Analysis
    10.3    Porter’s Five Forces Model
    10.4    Key Demand Indicators 
    10.5    Key Price Indicators
    10.6    Industry Events, Initiatives, and Trends  
    10.7    Value Chain Analysis
11    Global Allergy Treatment Market Segmentation
    11.1    Global Allergy Treatment Market by Type 
        11.1.1    Market Overview
        11.1.2    Eye Allergy
        11.1.3    Rhinitis
        11.1.4    Asthma
        11.1.5    Skin Allergy
        11.1.6    Food Allergies
        11.1.7    Others
    11.2    Global Allergy Treatment Market by Treatment
        11.2.1    Market Overview
        11.2.2    Anti-Allergy Drugs
            11.2.2.1    Antihistamine
            11.2.2.2    Corticosteroids
            11.2.2.3    Decongestants
            11.2.2.4    Other Drugs
        11.2.3    Immunotherapy
            11.2.3.1    Sub-Cutaneous Immunotherapy (SCIT)
            11.2.3.2    Sub-Lingual Immunotherapy (SLIT)
    11.3    Global Allergy Treatment Market by Route of Administration
        11.3.1    Market Overview
        11.3.2    Oral
        11.3.3    Inhalation
        11.3.4    Intranasal
        11.3.5    Others
    11.4    Global Allergy Treatment Market by End User 
        11.4.1    Market Overview
        11.4.2    Hospitals
        11.4.3    Specialty Clinics
        11.4.4    Homecare
        11.4.5    Others
    11.5    Global Allergy Treatment Market by Region
        11.5.1    Market Overview
        11.5.2    North America
        11.5.3    Europe 
        11.5.4    Asia Pacific
        11.5.5    Latin America
        11.5.6    Middle East and Africa
12    North America Allergy Treatment Market
    12.1    Market Share by Country
    12.2    United States of America
    12.3    Canada
13    Europe Allergy Treatment Market
    13.1    Market Share by Country
    13.2    United Kingdom
    13.3    Germany
    13.4    France
    13.5    Italy
    13.6    Others
14    Asia Pacific Allergy Treatment Market
    14.1    Market Share by Country
    14.2    China
    14.3    Japan
    14.4    India
    14.5    ASEAN
    14.6    Australia
    14.7    Others
15    Latin America Allergy Treatment Market
    15.1    Market Share by Country
    15.2    Brazil
    15.3    Argentina
    15.4    Mexico
    15.5    Others
16    Middle East and Africa Allergy Treatment Market
    16.1    Market Share by Country
    16.2    Saudi Arabia
    16.3    United Arab Emirates
    16.4    Nigeria
    16.5    South Africa
    16.6    Others
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Patent Analysis
    18.1    Analysis by Type of Patent
    18.2    Analysis by Publication year
    18.3    Analysis by Issuing Authority
    18.4    Analysis by Patent Age
    18.5    Analysis by CPC Analysis
    18.6    Analysis by Patent Valuation 
    18.7    Analysis by Key Players
19    Grants Analysis
    19.1    Analysis by year
    19.2    Analysis by Amount Awarded
    19.3    Analysis by Issuing Authority
    19.4    Analysis by Grant Application
    19.5    Analysis by Funding Institute
    19.6    Analysis by NIH Departments
    19.7    Analysis by Recipient Organization 
20    Clinical Trials Analysis
    20.1     Analysis by Trial Registration Year
    20.2    Analysis by Trial Status
    20.3    Analysis by Trial Phase
    20.4    Analysis by Therapeutic Area
    20.5    Analysis by Geography
21    Funding and Investment Analysis
    21.1    Analysis by Funding Instances
    21.2    Analysis by Type of Funding
    21.3    Analysis by Funding Amount
    21.4    Analysis by Leading Players
    21.5    Analysis by Leading Investors
    21.6    Analysis by Geography
22    Partnership and Collaborations Analysis
    22.1    Analysis by Partnership Instances
    22.2    Analysis by Type of Partnership
    22.3    Analysis by Leading Players
    22.4    Analysis by Geography
23    Supplier Landscape
    23.1    AbbVie Inc.
        23.1.1    Financial Analysis
        23.1.2    Product Portfolio
        23.1.3    Demographic Reach and Achievements
        23.1.4    Mergers and Acquisitions
        23.1.5    Certifications
    23.2    Sanofi S.A.
        23.2.1    Financial Analysis
        23.2.2    Product Portfolio
        23.2.3    Demographic Reach and Achievements
        23.2.4    Mergers and Acquisitions
        23.2.5    Certifications
    23.3    Johnson & Johnson Services, Inc.
        23.3.1    Financial Analysis
        23.3.2    Product Portfolio
        23.3.3    Demographic Reach and Achievements
        23.3.4    Mergers and Acquisitions
        23.3.5    Certifications
    23.4     LETI Pharma, S.L.U.
        23.4.1    Financial Analysis
        23.4.2    Product Portfolio
        23.4.3    Demographic Reach and Achievements
        23.4.4    Mergers and Acquisitions
        23.4.5    Certifications
    23.5    GlaxoSmithKline Plc.
        23.5.1    Financial Analysis
        23.5.2    Product Portfolio
        23.5.3    Demographic Reach and Achievements
        23.5.4    Mergers and Acquisitions
        23.5.5    Certifications
    23.6    Zenomed Healthcare Private Limited
        23.6.1    Financial Analysis
        23.6.2    Product Portfolio
        23.6.3    Demographic Reach and Achievements
        23.6.4    Mergers and Acquisitions
        23.6.5    Certifications
    23.7    F. Hoffmann-La Roche AG
        23.7.1    Financial Analysis
        23.7.2    Product Portfolio
        23.7.3    Demographic Reach and Achievements
        23.7.4    Mergers and Acquisitions
        23.7.5    Certifications
    23.8    Cadila Pharmaceuticals
        23.8.1    Financial Analysis
        23.8.2    Product Portfolio
        23.8.3    Demographic Reach and Achievements
        23.8.4    Mergers and Acquisitions
        23.8.5    Certifications
    23.9    Bayer AG
        23.9.1    Financial Analysis
        23.9.2    Product Portfolio
        23.9.3    Demographic Reach and Achievements
        23.9.4    Mergers and Acquisitions
        23.9.5    Certifications
    23.10    Teva Pharmaceutical Industries Ltd.
        23.10.1    Financial Analysis
        23.10.2    Product Portfolio
        23.10.3    Demographic Reach and Achievements
        23.10.4    Mergers and Acquisitions
        23.10.5    Certifications
    23.11    Akorn, Incorporated
        23.11.1    Financial Analysis
        23.11.2    Product Portfolio
        23.11.3    Demographic Reach and Achievements
        23.11.4    Mergers and Acquisitions
        23.11.5    Certifications
    23.12    Prestige Consumer Healthcare Inc.
        23.12.1    Financial Analysis
        23.12.2    Product Portfolio
        23.12.3    Demographic Reach and Achievements
        23.12.4    Mergers and Acquisitions
        23.12.5    Certifications
    23.13    Astellas Pharma Inc.
        23.13.1    Financial Analysis
        23.13.2    Product Portfolio
        23.13.3    Demographic Reach and Achievements
        23.13.4    Mergers and Acquisitions
        23.13.5    Certifications
    23.14    Eli Lilly and Company
        23.14.1    Financial Analysis
        23.14.2    Product Portfolio
        23.14.3    Demographic Reach and Achievements
        23.14.4    Mergers and Acquisitions
        23.14.5    Certifications
    23.15    Almirall, S.A
        23.15.1    Financial Analysis
        23.15.2    Product Portfolio
        23.15.3    Demographic Reach and Achievements
        23.15.4    Mergers and Acquisitions
        23.15.5    Certifications
24    Allergy Treatment - Distribution Model (Additional Insight)
    24.1    Overview 
    24.2    Potential Distributors 
    24.3    Key Parameters for Distribution Partner Assessment 
25    Key Opinion Leaders (KOL) Insights (Additional Insight)
26    Company Competitiveness Analysis (Additional Insight)

    26.1    Very Small Companies
    26.2    Small Companies
    26.3    Mid-Sized Companies
    26.4    Large Companies
    26.5    Very Large Companies
27    Payment Methods (Additional Insight)
    27.1    Government Funded
    27.2    Private Insurance
    27.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

Globally, allergy treatment market reached a value of USD 21.62 billion in 2023.

The market is projected to expand at a CAGR of 6.5% from 2024 to 2032, growing to USD 38.11 billion by 2032.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major drivers of the industry, such as the rising cases of allergy rhinitis, allergic asthma, conjunctivitis, and stinging insect allergy, among others, growing demand for immunology and anti-allergy drugs, the rising healthcare expenditure in emerging economies, and the growing awareness about the fatality of allergies, among others, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing investments in R&D activities in the field of medicine, along with the technological advancements in the healthcare infrastructure in emerging economies.

Eye allergy, rhinitis, asthma, skin allergy, and food allergies, among others are the major allergy treatment types.

Anti-allergy drugs and immunotherapy are the different kinds of treatments considered within the market report.

The major players in the industry are AbbVie Inc., GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd., Johnson & Johnson Services, Inc., Sanofi S.A., and LETI Pharma, S.L.U., among others.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER